In Other News

• Lower Killer T Cells Found in COVID-19 Patients Support ‘Prime and Boost’ Coronavirus Vaccine Model

• China Begins Human Trial for First COVID-19 Nasal Spray Vaccine

• AstraZeneca Oxford COVID-19 Vaccine Resumes Clinical Trials in UK; Launch by 2020 End Still Achievable

• New Tool Monitors SARS-CoV-2 Mutations That Make It Difficult to Develop COVID-19 Vaccines and Drugs

• Universal COVID-19 Antibody Test Could Identify Suitable Plasma Donors and Provide Critical Information on Coronavirus Immunity

• Repurposed Hepatitis C Drugs for COVID-19 Treatment Could Break Life Cycle of Coronavirus

• SARS-CoV-2 Found in 100% of Infected Patients' Stools Suggests COVID-19 Could Be a Gut Infection

• Microbiologics Launches IVD Process Controls and Inactivated Whole Virus Controls for SARS-CoV-2 Testing

• AstraZeneca Confirms Participant in COVID-19 Vaccine Trial Developed Rare But Serious Spinal Inflammatory Disorder

• Real-Time Imaging Shows How SARS-CoV-2 Attacks Human Cells

• Delayed Immune Response to SARS-CoV-2 Explain Why More Men Die from COVID-19

• Researchers Warn of Post-COVID-19 Kidney Disease Epidemic Linked to SARS-CoV-2

• South Korea's Celltrion to Begin Mass Production of Experimental COVID-19 Antibody Drug Ahead of EUA Approval

• DiaSorin Receives FDA Clearance for Simplexa Test That Differentiates Between COVID-19, Flu and RSV

• QIAGEN to Launch Rapid Portable COVID-19 Test That Can Analyze Over 30 Samples per Hour for SARS-CoV-2 Antigen

• Pfizer and BioNTech Announce Preclinical Data Supporting Efficacy for Phase 2/3 COVID-19 Vaccine

• AstraZeneca COVID-19 Vaccine Phase 3 Trials Halted After Suspected Adverse Reaction in UK Participant

• Pfizer and BioNTech Begin Phase 2/3 Clinical Trial for COVID-19 Vaccine Candidate in Germany

• COVID-19 Vaccine Makers Sign Historic Safety Pledge Upholding Integrity of Scientific Process

• Avacta Launches High Performance Affimer-Based SARS-CoV-2 ELISA Laboratory Test

• Korea’s Sugentech Granted FDA EUA for Gold Nanoparticle-Based Immunochromatographic COVID-19 Test

• New Antiviral COVID-19 Treatment to Be Used as Nasal Spray Could Be Made Available Over the Counter

• 3D Models Used for Research on Reptile and Bird Lungs Can Confirm Diagnosis of COVID-19 in Patients